PatientsLikeMe

PatientsLikeMe
Name	PatientsLikeMe
Type	Private
Industry	Health care, Technology
Founded	2004
Founders	Seth Sternberg, Hillary Johnson
Headquarters	Cambridge, Massachusetts
Area served	Global

PatientsLikeMe PatientsLikeMe is an online health information-sharing platform and patient network that connects individuals living with chronic conditions to share symptom reports, treatment outcomes, and quality-of-life data. Founded in the mid-2000s amid the rise of social networks and patient advocacy movements, the organization combines peer-to-peer support with structured data collection for observational research and real-world evidence generation. It has interacted with academic institutions, biopharmaceutical corporations, and regulatory agencies while influencing debates about patient-generated health data, digital health privacy, and open science.

History

The project's origins trace to collaborations among entrepreneurs and patient advocates influenced by examples such as Wikipedia, MySpace, Facebook, PatientsLikeMe (do not link), and early online patient forums like those around Cancer Research UK and American Cancer Society efforts. Founders sought to create a systematic way to aggregate longitudinal patient-reported outcomes informed by precedents from Harvard University research on health informatics and community-driven knowledge models exemplified by OpenStreetMap and ArXiv. Early adopters included communities affected by conditions that had visible advocacy networks such as Amyotrophic lateral sclerosis, Multiple sclerosis, and HIV/AIDS where organizations like ALS Association, National Multiple Sclerosis Society, and AIDS Project Los Angeles had already cultivated online engagement. Over subsequent years the platform expanded collaborations with research centers at Massachusetts Institute of Technology, University of California, San Francisco, Yale University, and King's College London, and engaged with regulatory dialogues involving U.S. Food and Drug Administration, European Medicines Agency, and ethics boards at major hospitals.

Platform and Services

The platform offers structured symptom trackers, medication logs, and outcome measures derived from validated instruments used in settings like Johns Hopkins Hospital and Mayo Clinic. Users create profiles and contribute longitudinal data that can be aggregated for cohorts, enabling analyses similar to those performed by teams at Stanford University, Columbia University, and University of Pennsylvania. Social features echo patterns found on Reddit and patient forums hosted by organizations such as HealthUnlocked and Inspire. The service has integrated standardized vocabularies and classifications used by institutions like SNOMED International, ICD-10, and medical record initiatives at Partners HealthCare to enable interoperability with electronic health record work at Epic Systems and Cerner Corporation. Tools support condition-specific communities for diseases that have active research consortia such as Alzheimer's Association, Parkinson's Foundation, and specialty registries tied to academic centers.

Data and Research Contributions

Aggregated, deidentified datasets have been used in peer-reviewed studies and collaborative projects with investigators at Harvard Medical School, University College London, University of Cambridge, and pharmaceutical research groups from companies like Novartis, Pfizer, and Roche. The model echoes citizen-science approaches championed by initiatives such as Foldit and data-sharing efforts like UK Biobank while also intersecting with regulatory real-world evidence frameworks from U.S. Food and Drug Administration guidance and observational methodologies applied at ClinicalTrials.gov. Published analyses have explored treatment effectiveness, adverse event patterns, and natural-history trajectories for conditions including multiple sclerosis, epilepsy, and amyotrophic lateral sclerosis. Collaborative work has contributed data to consortia associated with National Institutes of Health programs and influenced methodological debates in journals that feature researchers from The Lancet, New England Journal of Medicine, and JAMA.

Privacy, Ethics, and Data Security

The platform's practices have been scrutinized in light of privacy controversies that echo broader incidents involving Cambridge Analytica and data breaches at corporations such as Equifax and Anthem Inc.. Institutional review boards at institutions like Brigham and Women's Hospital and ethics committees at King's College London have evaluated protocols for informed consent, data deidentification, and secondary use. Discussions have engaged privacy scholars connected to Stanford Law School, bioethicists at Georgetown University, and technology policy researchers at Harvard Kennedy School. Security measures have been compared to industry practices at Google Health and compliance frameworks aligned with laws such as the Health Insurance Portability and Accountability Act and regulatory expectations from European Union privacy directives.

Business Model and Partnerships

Revenue and partnership models combine subscription or service agreements with pharmaceutical firms, contract research collaborations, and research grants from funders like Bill & Melinda Gates Foundation and government programs at National Institutes of Health. Corporate partnerships have involved biopharmaceutical companies including GlaxoSmithKline and AstraZeneca, contract research organizations, and academic medical centers like University of Michigan Health. Strategic transactions in the digital health sector—comparable to acquisitions involving 23andMe and mergers in digital therapeutics—have influenced investor interest from venture firms that previously funded startups emerging from accelerators like Y Combinator and Techstars.

Reception and Impact

The platform has been praised by patient advocacy groups such as Patient-Centered Outcomes Research Institute affiliates and cited by policy analysts at Brookings Institution and RAND Corporation for its role in patient-centered research and data democratization. Critics from privacy advocacy organizations like Electronic Frontier Foundation and academic commentators have raised concerns about commercialization of patient data and potential reidentification risks. Its model influenced subsequent patient-powered research networks and registries run by entities including PCORI-funded initiatives and disease-specific foundations. The legacy includes shifts in how stakeholders—patients, clinicians at institutions like Cleveland Clinic, researchers at NIH, and companies in the pharmaceutical sector—approach patient-generated data for evidence synthesis and healthcare innovation.

Category:Online patient communities